Fertility News and Research

RSS

Researchers find stress can delay pregnancy and double risk of infertility

Having difficulty getting pregnant can be an incredibly stressful experience for any couple. Now, for the first time, researchers have data that suggests preconception stress might play a role in infertility.

24 Mar 2014

TVM Capital Healthcare Partners signs affiliation with Joslin Diabetes Center

TVM Capital Healthcare Partners, the region's first private equity firm dedicated exclusively to the healthcare sector, has signed an affiliation with Joslin Diabetes Center.

17 Mar 2014

GE announces winners of the GE Healthcare 2013 Cell Imaging Competition

GE Healthcare Life Sciences (NYSE:GE) today announced Vanessa Auld from Canada, Martin Barr from Ireland and Graham Wright from Singapore as the winners of the GE Healthcare 2013 Cell Imaging Competition.

12 Mar 2014

Chronic smokers have altered emotional reactions when exposed to negative, positive images of tobacco

What if the use of a product influenced your perception of it, making you even more susceptible to its positive aspects and altering your understanding of its drawbacks? This is precisely what happens with cigarettes in chronic smokers, according to a recent study by the Institut universitaire en santé mentale de Montréal and University of Montreal.

11 Mar 2014

Antares Pharma announces launch of OTREXUP to Dermatologists

Antares Pharma, Inc. today announced LEO Pharma's launch of OTREXUP to Dermatologists, the first U.S. Food and Drug Administration approved subcutaneous (SC) methotrexate (MTX) product for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.

10 Mar 2014

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

Safeguard Scientifics, Inc. today announced fourth quarter and full-year 2013 financial results. For the three months ended December 31, 2013, Safeguard's net income was $24.0 million, or $1.10 per share, compared to net loss of $10.8 million, or $0.51 per share for the same period in 2012. For the year ended December 31, 2013, Safeguard's net loss was $35.5 million, or $1.66 per share, compared to $39.4 million, or $1.88 per share for the same period in 2012.

6 Mar 2014

New study assesses effectiveness of two surgical treatments for ectopic pregnancy

A new study from Wake Forest Baptist Medical Center looked at pregnancy outcomes in regards to the two surgical treatments for ectopic pregnancy -- salpingectomy, in which the affected fallopian tube is removed, or salpingotomy, in which the tube is preserved.

6 Mar 2014

New study shows male hormones play important role; may enhance IVF therapy in women

Several fertility clinics across the country are beginning to administer testosterone, either through a patch or a gel on the skin, to increase the number of eggs produced by certain women undergoing in vitro fertilization (IVF).

5 Mar 2014

Majority of women experience reproductive coercion and intimate partner violence

Enough women experience reproductive coercion - male behavior to control contraception and pregnancy outcomes - that a research team now recommends health care providers address the subjects with their patients and tailor family planning discussions and recommendations accordingly.

4 Mar 2014

Sports medicine experts raise concern about female athlete triad syndrome

When an adolescent female patient comes to Nationwide Children's Hospital's Sports Medicine clinic, not only are these young women treated for their sports-related injury, but their sports medicine physician will also ask if they've missed any periods, because of a growing concern among female athletes.

18 Feb 2014

UCLA researchers publish landmark meta-analysis of sexual preferences at ovulation

If she loves you and then she loves you not, don't blame the petals of that daisy. Blame evolution.

17 Feb 2014

Researchers develop new model for isolating effects of nutrients on gene expression, physiology

Everyday our cells take in nutrients from food and convert them into the building blocks that make life possible. However, it has been challenging to pinpoint exactly how a single nutrient or vitamin changes gene expression and physiology.

14 Feb 2014

New video tracking system could help select most viable sperm

To improve their chances of success, in vitro fertilization (IVF) clinics need to assess the viability of the sperm they use. Now doctors may soon have a new technique to help them sort the good sperm cells from the less viable ones: a tracking system, developed by a team of researchers from four European institutions, that takes 3-D movies of living sperm.

12 Feb 2014

Study examines trends in fertility rates among girls with mental illness

Young girls with mental illness are three times more likely to become teenage parents than those without a major mental illness, according to a first-of-its-kind study by researchers at the Institute for Clinical Evaluative Sciences and Women's College Hospital.

10 Feb 2014

Women with schizophrenia twice as likely to experience pre-term birth and pregnancy complications

Women with schizophrenia are nearly twice as likely to experience pre-eclampsia, pre-term birth and other serious pregnancy and delivery complications as women without the condition, a landmark study by researchers at the Institute for Clinical Evaluative Sciences (ICES) and Women's College Hospital has found.

4 Feb 2014

Women who have child after experiencing fertility problems are more likely to remain with partner

New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.

30 Jan 2014

Study: About 50% of reproductive-age women never discussed reproductive health with medical provider

A new study by Yale School of Medicine researchers provides insight into how much women of reproductive age in the United States know about reproductive health.

28 Jan 2014

TherapeuticsMD starts TX 12-002-HR phase 3 clinical trial for secondary amenorrhea

TherapeuticsMD, Inc., a women's healthcare company, announced today that it has initiated the SPRY Trial, a randomized, placebo-controlled phase 3 clinical trial designed to evaluate the safety and efficacy of TX 12-002-HR, its oral progesterone candidate for secondary amenorrhea, a condition treated to maintain fertility in young premenopausal women.

24 Jan 2014

NICE approves MabThera for treating severe forms of GPA and MPA

Today the National Institute for Health and Care Excellence has approved the use of MabThera for two potentially life-threatening auto-immune diseases, GPA and MPA, which result in the inflammation and damage of small blood vessels and frequently involve multiple organs. The two diseases affect over 13,000 people in the UK and are characterised by the breaking down of specific areas of tissue in the body that, if not treated, can lead to organ damage, organ failure and even death.